Ann: VitroGro ECM CE Mark Approval Referred to MH, page-7

re: Ann: VitroGro ECM CE Mark Approval Referr... On the same day that TIS gets fobbed off to another European regulatory agency, Genetic Technologies (GTG) receives CE Mark (device) approval for BREVAGen!

Meanwhile, thousands of suffers with chronic wounds across Europe (and the world) continue to face the prospect of chronic pain and amputation. And all of this, just because a regulatory agency can't decide which device number should be allocated to a new (and unique) healing product VitroGro.

Is it any wonder that Europe and the UK economies are in such dire straits? A little Aussie company is trying to save them multiple millions of dollars and they can't decide between the device numbers 8 or 11 (lol).

Regards,

Goggo